ArrowMark Colorado Holdings LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 195 filers reported holding NEKTAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
ArrowMark Colorado Holdings LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2019$3,890,000
-43.3%
109,330
-46.5%
0.04%
-43.1%
Q1 2019$6,865,000
-29.8%
204,330
-31.3%
0.06%
-36.3%
Q4 2018$9,774,000
-53.8%
297,330
-14.4%
0.10%
-42.7%
Q3 2018$21,173,000
+75.5%
347,330
+40.6%
0.18%
+61.8%
Q2 2018$12,061,000
-42.6%
246,997
+24.9%
0.11%
-47.6%
Q1 2018$21,016,000
-18.3%
197,777
-54.1%
0.21%
-19.2%
Q4 2017$25,726,000
+133.5%
430,777
-6.1%
0.26%
+108.0%
Q3 2017$11,016,000
+22.8%
458,9970.0%0.12%
+12.6%
Q2 2017$8,973,000
-4.2%
458,997
+15.0%
0.11%
-13.3%
Q1 2017$9,364,000
+78.7%
398,997
-6.6%
0.13%
+54.2%
Q4 2016$5,240,000
-28.6%
427,0980.0%0.08%
-37.6%
Q3 2016$7,338,000
+5.3%
427,098
-12.8%
0.13%
-5.7%
Q2 2016$6,971,000
+3.5%
489,8930.0%0.14%
-6.0%
Q1 2016$6,736,000
+0.5%
489,893
+23.1%
0.15%
-18.0%
Q4 2015$6,705,000
+53.7%
397,9050.0%0.18%
+53.8%
Q3 2015$4,361,000
-4.5%
397,905
+9.0%
0.12%
+7.2%
Q2 2015$4,565,000
+13.7%
364,9050.0%0.11%
+6.7%
Q1 2015$4,014,000
+1397.8%
364,905
+2009.3%
0.10%
+1385.7%
Q4 2014$268,000
+28.2%
17,3000.0%0.01%
+16.7%
Q3 2014$209,000
-5.9%
17,3000.0%0.01%0.0%
Q2 2014$222,000
+5.7%
17,3000.0%0.01%
-14.3%
Q1 2014$210,000
+7.1%
17,3000.0%0.01%
+16.7%
Q4 2013$196,000
-52.1%
17,300
-55.9%
0.01%
-53.8%
Q3 2013$409,000
+104.5%
39,189
+126.5%
0.01%
-75.9%
Q2 2013$200,00017,3000.05%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2016
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 598,400$10,083,0003.98%
Opus Point Partners Management, LLC 348,583$5,874,0003.88%
Camber Capital Management LP 3,500,000$58,975,0003.81%
1492 Capital Management LLC 180,601$3,043,0002.21%
Virtus ETF Advisers LLC 38,260$645,0001.77%
Cormorant Asset Management, LP 765,156$12,893,0001.54%
Rhenman & Partners Asset Management AB 581,000$9,790,0001.48%
Granahan Investment Management 2,082,155$35,084,0001.21%
BRIDGER MANAGEMENT, LLC 1,563,862$26,351,0000.87%
RICE HALL JAMES & ASSOCIATES, LLC 899,531$15,157,0000.87%
View complete list of NEKTAR THERAPEUTICS shareholders